---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-007359"
form_type: "8-K"
ticker: "PMCB"
cik: "0001157075"
company_name: "PharmaCyte Biotech, Inc."
filed_at: "2022-11-07T23:59:59+00:00"
generated_at: "2026-06-22T05:01:04.249055+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Jack E. Stover resigns from PharmaCyte Biotech board effective Nov 1, 2022

## Summary
- Jack E. Stover resigned from the board of directors effective November 1, 2022.
- Resignation was not due to any disagreement with the company.
- No replacement for Mr. Stover was announced in the filing.

## SEC filing metadata
- accession: 0001683168-22-007359
- form_type: 8-K
- ticker: PMCB
- cik: 0001157075
- company_name: PharmaCyte Biotech, Inc.
- filed_at: 2022-11-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1157075/000168316822007359/0001683168-22-007359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1157075/000168316822007359/pharmacyte_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-007359
- JSON: https://secwatch.observer/filing/0001683168-22-007359.json
- Plain text: https://secwatch.observer/filing/0001683168-22-007359.txt

## Key facts
- Executive change
  Jack E. Stover resigned as Director at PharmaCyte Biotech, Inc..
  - Action: resigned
  - Role: Director
  source text: On November 1, 2022, Jack E. Stover notified PharmaCyte Biotech, Inc. (the “Company”) of his decision to resign from the board of directors of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1157075/000168316822007359/0001683168-22-007359-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.